Correlation Between Flowtech Fluidpower and Viridian Therapeutics

Can any of the company-specific risk be diversified away by investing in both Flowtech Fluidpower and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Flowtech Fluidpower and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Flowtech Fluidpower plc and Viridian Therapeutics, you can compare the effects of market volatilities on Flowtech Fluidpower and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Flowtech Fluidpower with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Flowtech Fluidpower and Viridian Therapeutics.

Diversification Opportunities for Flowtech Fluidpower and Viridian Therapeutics

0.85

Correlation Coefficient

Flowtech Fluidpower  Viridian Therapeutics

Very poor diversification

The 3 months correlation between Flowtech and Viridian is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Flowtech Fluidpower plc and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Flowtech Fluidpower is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Flowtech Fluidpower plc are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Flowtech Fluidpower i.e., Flowtech Fluidpower and Viridian Therapeutics go up and down completely randomly.

Pair Corralation between Flowtech Fluidpower and Viridian Therapeutics

Assuming the 90 days trading horizon Flowtech Fluidpower plc is expected to under-perform the Viridian Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Flowtech Fluidpower plc is 1.51 times less risky than Viridian Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Viridian Therapeutics is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest  1,945  in Viridian Therapeutics on December 30, 2024 and sell it today you would lose (483.00) from holding Viridian Therapeutics or give up 24.83% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Flowtech Fluidpower plc  vs.  Viridian Therapeutics

Flowtech Fluidpower plc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Flowtech Fluidpower plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Viridian Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Flowtech Fluidpower and Viridian Therapeutics

The main advantage of trading using opposite Flowtech Fluidpower and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Flowtech Fluidpower position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.

The idea behind Flowtech Fluidpower plc and Viridian Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .